ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0006284;base-excision repair;8.0;0.9326813400603323;0.8413406700301662;9.584072489921288;183.0506323445446;5.69953618377475;0.006126539929698291;0.6664745454937787;[POLB]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[TRAM1, AHCYL1, SYS1, RABGAP1, CLTA, HSD17B4, TRAK1, NAPG, RAB21, EIF4ENIF1, AP3M1, NUP62, VPS11, TMED2, EVI5L, TNPO2, SNAP29, TBC1D22A, ATP6V1F, RAB8B, RPL19, PEX16, VPS18, TMED9, PDCD6IP, PEX19, SSR2, VPS33B, COG3, RHBDF2, SYVN1, NUP153, SENP2, ARCN1, BCR, PAN3, GAL, SNX17, VPS41, RAB18, SEC24C, SLU7, KPNB1, PAFAH1B1, EXOC1]
GO:0006288;base-excision repair, DNA ligation;9.0;1.0;0.896240625180289;9.628524252492122;150.14073953485922;8.67846133901236;0.005025075434338753;0.8400575416471059;[POLB]
GO:0043320;natural killer cell degranulation;9.0;1.0;0.896240625180289;9.628524252492122;133.05394577034187;8.16763571524637;0.004453195824156379;0.8139338954918922;[UNC13D]
GO:0006286;base-excision repair, base-free sugar-phosphate removal;8.0;1.0;0.875;9.628524252492122;287.9987222070764;9.083926447120524;0.009639058050248383;0.839552420951524;[POLB]
GO:0006287;base-excision repair, gap-filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;8.16763571524637;0.0049883058697239;0.7686126355688037;[POLB]
GO:0042058;regulation of epidermal growth factor receptor signaling pathway;7.0;0.7369933605727446;0.7194160455435727;8.992535485772125;43.237532372156394;5.395046993006588;0.001447121297243272;0.6268223193749;[NUP62, RHBDF2]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[IFNAR2]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, AQR, SF3B2, GPKOW, BUD31, CPSF2, DDX42, DDX41, USP39, SRRM1, EFTUD2, PABPN1, PCF11, U2AF2, POLR2B, SNRPG, SNRPB2, POLR2G, SLU7, SMNDC1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[NPPA, UNC13D]
GO:1903307;positive regulation of regulated secretory pathway;9.0;0.7090535922965819;0.75076742132858;9.027750392063192;236.78497455026974;5.948432231191374;0.007924980005555578;0.7004437261138039;[NPPA, UNC13D]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[POLB, ITPR2]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[KIAA1109, SYNJ1]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[POLE4, POLB, SMG5]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, ITCH, POLR3C, DDX41, SERINC3, UNC13D, EXOC1]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[YY1, PSMD8, POLB, BECN1, VCPIP1, WDR48, PSMB1, OTUD7B, USP51, USP39]
GO:0071707;immunoglobulin heavy chain V-D-J recombination;12.0;1.0;0.9481203125901445;9.628524252492122;336.7572125558621;9.777073627680469;0.011270960842429843;0.9481203125901445;[POLB]
GO:0006290;pyrimidine dimer repair;8.0;0.8933024483968273;0.8216512241984136;9.541512875502493;183.0506323445446;7.57984905034425;0.006126539929698291;0.7626338329336335;[POLB]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[RIC8A, HEBP1, ABR, AHCYL1, GNG2, GAL, SPHK2, NPPA, OR56B1, IQGAP2, CALM1]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[PHF3, SETD5, ONECUT2, NAB1, INTS10, ARID4A, HOXC13, CHD1, YY1, NIPBL, ZMYM2, SAP130, NUP62, DPF2, TRIM24, ZNF768, EP300, ZNF326, LRRFIP1, ZNF564, IER2, TLE4, TBP, CSNK2A1, BUD31, COMMD3, ZFX, SND1, MED29, ERN1, LCOR, VGLL4, ZNF394, HDAC3, HDAC1, WBP2, FOXG1, RLF, POLR2B, POLR2G, SUDS3, ASCC3, ZNF189, TRAPPC2, TBX1, DR1, NFYC, INTS3, PBX3, CNOT10, GRHL1, USF2, FLI1, SOX30, CDK9, CNOT6, TFCP2, CNOT1, POLR3C, NFIC, SP3, ZNF658, INTS4, TAF7, CNOT8]
GO:0050709;negative regulation of protein secretion;8.0;0.6493065804076676;0.6996532902038338;8.749274792298316;381.9718045319581;5.058574756385375;0.01278425254537885;0.6336957482893315;[RHBDF2]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[IFNAR2]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[POLB, CASP2, EP300]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[PDXK, TMEM30A, PSMB1, RAB18, COMMD3, DOCK2, IQGAP2, SNAP29, KPNB1, UNC13D, SERPINB6]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[CIB1, UNC13D]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TIFA]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNAR2]
GO:0002467;germinal center formation;5.0;1.0;0.7902410118609202;9.628524252492122;29.459500770284833;7.697632086000634;9.859829789520339E-4;0.6838982747154925;[UNC13D]
GO:0030856;regulation of epithelial cell differentiation;5.0;0.5577261244500507;0.5691040740859457;7.75672207559053;54.42428208907013;4.87179884924204;0.001821531742847262;0.5393850315729737;[KIAA1109, GRHL1]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[RAB21, MTPN, ITCH, KIAA1109, GAL, CSNK2A1, NPPA, CIB1, PAFAH1B1]
GO:2000825;positive regulation of androgen receptor activity;12.0;1.0;0.9481203125901445;9.628524252492122;1282.7688761636532;8.390779266560578;0.04293311986816003;0.8772251544931927;[BUD31]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ITGB3, TM9SF4, UNC13D]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[RHBDF2, CASP2]
